Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125851281 | 12585128 | 1 | I | 20160704 | 20160715 | 20160723 | 20160723 | EXP | GB-MHRA-ADR 23558279 | GB-ACCORD-042624 | ACCORD | 87.00 | YR | M | Y | 0.00000 | 20160723 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125851281 | 12585128 | 1 | PS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | Y | 202925 | 75 | MG | QD | |||||||
| 125851281 | 12585128 | 2 | SS | CLEXANE | ENOXAPARIN SODIUM | 1 | Subcutaneous | 9960 | MG | 0 | 120 | MG | QD | ||||||
| 125851281 | 12585128 | 3 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | DOSE INCREASED. | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125851281 | 12585128 | 1 | Antiplatelet therapy |
| 125851281 | 12585128 | 2 | Deep vein thrombosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125851281 | 12585128 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125851281 | 12585128 | Gastritis haemorrhagic | |
| 125851281 | 12585128 | Haematemesis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125851281 | 12585128 | 1 | 20160704 | 0 | ||
| 125851281 | 12585128 | 2 | 20160412 | 0 |